2:59 [STO Spotlight] Unedited Jacob Sands on a new DLL3-targeted autologous CAR-T cell therapy in SCLC P2PMD 348 views - 10 months ago
0:53 [Trailer] CMVD Series Episode 1 - Venous Health, the Link Between CVD & HD P2PMD 92.6K views - 5 months ago
3:07 [STO Spotlight] Unedited Paulo Siqueira on Amaral on Efficacy of treatment after therapy in nccRCC P2PMD 255 views - 10 months ago
1:43 [STO Spotlight] Unedited Dirk Arnold on OrigAMI-2 in left-sided RAS/BRAF wild-type mCRC P2PMD 235 views - 7 months ago
4:15 [STO Spotlight] Unedited Jason Luke on SUPRAME: Ph3 IMA203 in advanced cutaneous melanoma (unedited) P2PMD 938 views - 10 months ago
4:37 [STO Spotlight] Unedited Joel Hecht on OrigAMI-3 in RAS/BRAF wild-type colorectal cancer P2PMD 432 views - 7 months ago
1:01 [STO Spotlight] Unedited Jared Weiss on PDS0101&pembrolizumab boost HPV+head-neck cancer survival P2PMD 347 views - 10 months ago
6:31 [STO Spotlight] Unedited Sarah Sammons on update to ReDiscover trial P2PMD 456 views - 1 year ago
6:26 [STO Spotlight] Unedited Reva Basho on AI Prediction of HER2+ BC treatment response P2PMD 2.7K views - 1 month ago
2:35 [STO Spotlight] Unedited Paolo Tarantino on Immune, Genetic, TILs as predictors for TNBC outcomes P2PMD 476 views - 9 months ago
5:20 [STO Spotlight] Unedited Ronan Kelly on Falcon Registry: Early Cancer Detection Evidence P2PMD 716 views - 10 months ago
4:52 [STO Spotlight] Unedited Matt Goetz on Phase II Z-Endoxifen vs Tamoxifen in refractory ER+ HER2− MBC P2PMD 1.3K views - 1 month ago
3:31 [STO Spotlight] Unedited Deepak Vadehra on Obesity in Colon Cancer P2PMD 1.8K views - 1 month ago
3:10 [STO Spotlight] Unedited Priyanka Sharma on ImPrintTN signature and TNBC survival outcomes P2PMD 296 views - 10 months ago
4:08 [STO Spotlight] Unedited Reshma Mahtani on Analysis of Biomarker Concordance and occurence P2PMD 2.2K views - 1 month ago
2:18 [STO Spotlight] Unedited Richard Finn on LEAP-002 in advanced hepatocellular carcinoma P2PMD 217 views - 7 months ago
6:42 [STO Spotlight] Unedited Raymond Osarogiagbon on disparity in outcomes for targeted therapy in NSCLC P2PMD 196 views - 10 months ago
4:23 [STO Spotlight] Unedited Ruth O'Regan on identifying early stage BC patients P2PMD 2.3K views - 1 month ago